Evidence map›Paper›PMID 28902136›Full record

ArticleInternational journal of molecular sciences2017

Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.

Atsushi Okato, Takayuki Arai, Yasutaka Yamada, Sho Sugawara, Keiichi Koshizuka, Lisa Fujimura, Akira Kurozumi, Mayuko Kato, Satoko Kojima, Yukio Naya and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 61 citations in OpenAlex.

  1. Targeting miRNAs in renal cell carcinoma: emerging therapeutic strategies.International journal of clinical oncology · 2025
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. The Immune-related ceRNA Network in Prognosis of Cervical Cancer.Asian Pacific journal of cancer prevention : APJCP · 2022
    Article
  9. Tumor-Suppressive and Oncogenic Roles of microRNA-149-5p in Human Cancers.International journal of molecular sciences · 2022
    Review
  10. Article
  11. A Review on the Role of miR-149-5p in the Carcinogenesis.International journal of molecular sciences · 2021
    Review
  12. A Review of Recent Research on the Role of MicroRNAs in Renal Cancer.Medical science monitor : international medical journal of experimental and clinical research · 2021
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. MicroRNA Signature in Renal Cell Carcinoma.Frontiers in oncology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Atsushi OkatoDepartment of Functional Genomics, Chiba University Graduate School of Medicine, 2608670 Chiba, Japan. aexa5919@chiba-u.jp.
Takayuki AraiDepartment of Functional Genomics, Chiba University Graduate School of Medicine, 2608670 Chiba, Japan. agda0043@chiba-u.jp.
Yasutaka YamadaDepartment of Functional Genomics, Chiba University Graduate School of Medicine, 2608670 Chiba, Japan. yasutaka1205@chiba-u.jp.
Sho SugawaraDepartment of Functional Genomics, Chiba University Graduate School of Medicine, 2608670 Chiba, Japan. afha7393@chiba-u.jp.
Keiichi KoshizukaDepartment of Functional Genomics, Chiba University Graduate School of Medicine, 2608670 Chiba, Japan. aeha4003@chiba-u.jp.
Lisa FujimuraDepartment of Biomedical Science, Chiba University Graduate School of Medicine, 2608670 Chiba, Japan. lisaf1227@faculty.chiba-u.jp.
Akira KurozumiDepartment of Functional Genomics, Chiba University Graduate School of Medicine, 2608670 Chiba, Japan. adfa2718@chiba-u.jp.
Mayuko KatoDepartment of Functional Genomics, Chiba University Graduate School of Medicine, 2608670 Chiba, Japan. mayukokato@chiba-u.jp.
Satoko KojimaDepartment of Urology, Teikyo University Chiba Medical Center, 2990111 Ichihara, Japan. kojima-s@med.teikyo-u.ac.jp.
Yukio NayaDepartment of Urology, Teikyo University Chiba Medical Center, 2990111 Ichihara, Japan. nayay@med.teikyo-u.ac.jp.
Tomohiko IchikawaDepartment of Urology, Chiba University Graduate School of Medicine, 2608670 Chiba, Japan. tomohiko_ichikawa@faculty.chiba-u.jp.
Naohiko SekiDepartment of Functional Genomics, Chiba University Graduate School of Medicine, 2608670 Chiba, Japan. naoseki@faculty.chiba-u.jp.
Chiba University · JPTeikyo University Chiba Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our recent studies revealed that dual strands of certain pre-microRNAs, e.g., pre-

Indexed as

AdultAgedAged, 80 and overAntineoplastic AgentsCarcinoma, Renal CellCell Line, TumorCell MovementCell ProliferationDown-RegulationFemaleForkhead Box Protein M1Gene Expression ProfilingGene Knockdown TechniquesHumansImmunohistochemistryKidney NeoplasmsAntineoplastic AgentsForkhead Box Protein M1FOXM1 protein, humanMicroRNAsMIRN149 microRNA, humanantitumorclear cell renal cell carcinomaFOXM1microRNAmiR-149-3pmiR-149-5p

Identifiers

PMID28902136
PMCPMC5618618
OpenAlexW2755611443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.